Rafferty Asset Management, LLC Moderna, Inc. Transaction History

Rafferty Asset Management, LLC

$26.8 Billion
Q2 2024

A detailed history of Rafferty Asset Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 261,760 shares of MRNA stock, worth $17.2 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

261,760

Previous 243,162 7.65%

Holding current value

$17.2 Million

Previous $25.9 Million 19.96%

% of portfolio

0.12%

Previous 0.1%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$101.21 - $166.61 $1.88 Million - $3.1 Million	18,598 Added 7.65%	261,760 $31.1 Million
Q1 2024 May 13, 2024	SELL	$85.37 - $115.44 $2.4 Million - $3.25 Million	-28,167 Reduced 10.38%	243,162 $25.9 Million
Q4 2023 Feb 13, 2024	BUY	$69.51 - $104.43 $5.59 Million - $8.41 Million	80,487 Added 42.17%	271,329 $27 Million
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $3.25 Million - $4.27 Million	33,694 Added 21.44%	190,842 $19.7 Million
Q2 2023 Aug 11, 2023	BUY	$118.5 - $160.53 $4.66 Million - $6.31 Million	39,299 Added 33.35%	157,148 $19.1 Million
Q1 2023 May 11, 2023	BUY	$135.66 - $197.02 $2.19 Million - $3.18 Million	16,136 Added 15.86%	117,849 $18.1 Million
Q4 2022 Feb 13, 2023	SELL	$118.38 - $210.04 $2.24 Million - $3.97 Million	-18,924 Reduced 15.69%	101,713 $18.3 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $3.49 Million - $5.75 Million	29,601 Added 32.52%	120,637 $14.3 Million
Q2 2022 Aug 12, 2022	BUY	$117.13 - $176.59 $325,621 - $490,920	2,780 Added 3.15%	91,036 $13 Million
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $5.18 Million - $9.63 Million	40,968 Added 86.64%	88,256 $15.2 Million
Q4 2021 Feb 10, 2022	BUY	$225.82 - $368.51 $4.37 Million - $7.14 Million	19,369 Added 69.38%	47,288 $12 Million
Q3 2021 Nov 10, 2021	SELL	$221.9 - $484.47 $572,280 - $1.25 Million	-2,579 Reduced 8.46%	27,919 $10.7 Million
Q2 2021 Aug 10, 2021	SELL	$129.91 - $234.98 $2.41 Million - $4.36 Million	-18,565 Reduced 37.84%	30,498 $7.17 Million
Q1 2021 May 10, 2021	BUY	$109.18 - $185.98 $1.82 Million - $3.11 Million	16,706 Added 51.63%	49,063 $6.43 Million
Q4 2020 Feb 10, 2021	SELL	$65.74 - $169.86 $2.69 Million - $6.94 Million	-40,865 Reduced 55.81%	32,357 $3.38 Million
Q3 2020 Nov 13, 2020	BUY	$54.34 - $94.85 $3.13 Million - $5.46 Million	57,565 Added 367.66%	73,222 $5.18 Million
Q2 2020 Aug 07, 2020	SELL	$29.67 - $80.0 $103,548 - $279,200	-3,490 Reduced 18.23%	15,657 $1.01 Million
Q1 2020 May 15, 2020	SELL	$17.78 - $31.58 $2.55 Million - $4.53 Million	-143,597 Reduced 88.23%	19,147 $573,000
Q4 2019 Feb 10, 2020	BUY	$13.93 - $21.28 $2.27 Million - $3.46 Million	162,744 New	162,744 $3.18 Million

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Moderna, Inc. Transaction History